Preferred Label : chlorquinaldol;
MeSH definition : Local anti-infective agent used for skin, gastrointestinal, and vaginal infections
with fungi, protozoa, and certain bacteria. In animals, it causes central nervous
system damage and is not administered parenterally. It is also used as antiseptic,
fungistat, or deodorant.;
MeSH synonym : chlorchinaldine; chloroquinaldol; 5,7 dichloro 2 methyl 8 quinolinol; chlorchinaldol; 5,7-dichloro-2-methyl-8-quinolinol;
MeSH hyponym : afungil; sterosan;
MeSH CAS label : 8-Quinolinol, 5,7-dichloro-2-methyl-;
MeSH Related Number : 72-80-0 (Chlorquinaldol);
Registry Number MeSH : 72-80-0;
Codes EINECS : 200-789-3;
Is substance : O;
UNII : D6VHC87LLS;
InChIKey : GPTXWRGISTZRIO-UHFFFAOYSA-N;
Origin ID : D002750;
UMLS CUI : C0008292;
ATC code(s)
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
Local anti-infective agent used for skin, gastrointestinal, and vaginal infections
with fungi, protozoa, and certain bacteria. In animals, it causes central nervous
system damage and is not administered parenterally. It is also used as antiseptic,
fungistat, or deodorant.
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-05/colposeptine_-_ct-_9692.pdf
http://www.has-sante.fr/portail/jcms/c_1050849/colposeptine
2011
France
French
evaluation of the transparency committee
drug combinations
administration, intravaginal
chlorquinaldol
promestriene
estradiol
anti-infective agents
estradiol congeners
insurance, health, reimbursement
atrophy
vagina
superinfection
chlorquinaldol
---
http://www.has-sante.fr/portail/jcms/c_817334/colposeptine
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-07/colposeptine-_ct-5818.pdf
2009
France
French
drug combinations
chlorquinaldol
anti-infective agents
promestriene
estradiol
insurance, health, reimbursement
estrogens, combinations with other drugs
estradiol congeners
administration, intravaginal
atrophy
vagina
treatment outcome
superinfection
evaluation of the transparency committee
---